For the first time but most certainly not the last, programs right here in Waseca County are set to benefit from the ...

Over the past 12 months, hundreds of peer-reviewed cannabis-related studies have been released, covering everything from pain management and neurological conditions to cancer biology, metabolic health ...

A major policy shift in Pennsylvania now allows opioid settlement funds for public defenders, a move that could be ...

From CBD to kratom to nootropics, the active ingredients at the center of this growing industry may lead to serious health ...

A study has shown that unlike opioids like morphine, the experimental painkiller does not cause tolerance, meaning you don't ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...

Opioid Analgesics, Addiction, Prescription Practices, Healthcare Professionals, Dakar Samba, O. , Fall, D. , Ba, I. , Ndiaye, I. , Dieye, M. , Dieye, N. and Sylla, A. (2026) Knowledge and Attitudes of ...

Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...

In just the first three weeks of 2026, lawmakers in multiple states have filed numerous proposals related to kratom, the herbal product derived from the Mitragyna speciosa plant that is widely sold in ...

Medical cannabis remains the only controlled substance in the state for which physicians cannot monitor patient use, confirm dosing, or intervene when patterns of risky behavior emerge ...

Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.

The company also stands to gain from recent regulatory FDA guidance aimed at streamlining the development of non-opioid ...